|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Cotton SW, Kornegay JN, Bogan DJ, Wadosky
KM, Patterson C and Willis MS: Genetic myostatin decrease in the
golden retriever muscular dystrophy model does not significantly
affect the ubiquitin proteasome system despite enhancing the
severity of disease. Am J Transl Res. 6:43–53. 2013.PubMed/NCBI
|
|
3
|
Arthur JS, Elce JS, Hegadorn C, Williams K
and Greer PA: Disruption of the murine calpain small subunit gene,
Capn4: Calpain is essential for embryonic development but not for
cell growth and division. Mol Cell Biol. 20:4474–4481. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Suzuki K, Hata S, Kawabata Y and Sorimachi
H: Structure, activation, and biology of calpain. Diabetes. 53
(Suppl 1):S12–S18. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Huang Y and Wang KK: The calpain family
and human disease. Trends Mol Med. 7:355–362. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Gonzalez A, Abril E, Roca A, Aragón MJ,
Figueroa MJ, Velarde P, Royo JL, Real LM and Ruiz A: CAPN10 alleles
are associated with polycystic ovary syndrome. J Clin Endocrinol
Metab. 87:3971–3976. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ehrmann DA, Schwarz PE, Hara M, Tang X,
Horikawa Y, Imperial J, Bell GI and Cox NJ: Relationship of
calpain-10 genotype to phenotypic features of polycysticovary
syndrome. J Clin Endocrinol Metab. 87:1669–1673. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Ohno S, Minoshima S, Kudoh J, Fukuyama R,
Shimizu Y, Ohmi-Imajoh S, Shimizu N and Suzuki K: Four genes for
the calpain family locate on four distinct human chromosomes.
Cytogenet Cell Genet. 53:225–229. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Storr SJ, Thompson N, Pu X, Zhang Y and
Martin SG: Calpain in breast cancer: Role in disease progression
and treatment response. Pathobiology. 82:133–141. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Storr SJ, Carragher NO, Frame MC, Parr T
and Martin SG: The calpain system and cancer. Nat Rev Cancer.
11:364–374. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
11
|
Storr SJ, Woolston CM, Barros FF, Green
AR, Shehata M, Chan SY, Ellis IO and Martin SG: Calpain-1
expression is associated with relapse-free survival in breast
cancer patients treated with trastuzumab following adjuvant
chemotherapy. Int J Cancer. 129:1773–1780. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Luo W, Ren Z, Gao S, Jin H, Zhang G, Zhou
L and Zheng S: Clinical correlation of calpain-1 and glypican-3
expression with gallbladder carcinoma. Oncol Lett. 11:1345–1352.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Salehin D, Fromberg I, Haugk C, Dohmen B,
Georg T, Bohle RM, Bauerschlag D, Maass N and Friedrich M:
Immunhistochemical analysis for expression of calpain 1, calpain 2
and calpastatin in endometrial cancer. Anticancer Res.
30:2837–2843. 2010.PubMed/NCBI
|
|
14
|
Kovacs L and Su Y: The critical role of
calpain in cell proliferation. Biomol Res Ther. 3:1122014.
|
|
15
|
Tian ZQ, Shi JW, Wang XR, Li Z and Wang
GY: New cancer suppressor gene for colorectal adenocarcinoma:
Filamin A. World J Gastroenterol. 21:2199–2205. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guroff G: A neutral, calcium-activated
proteinase from the soluble fraction of rat brain. J Biol Chem.
239:149–155. 1964.PubMed/NCBI
|
|
17
|
Azam M, Andrabi SS, Sahr KE, Kamath L,
Kuliopulos A and Chishti AH: Disruption of the mouse mu-calpain
gene reveals an essential role in platelet function. Mol Cell Biol.
21:2213–2220. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Sorimachi H, Hata S and Ono Y: Impact of
genetic insights into calpain biology. J Biochem. 150:23–37. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Van Ba H and Inho H: Significant role of
µ-calpain (CANP1) in proliferation/survival of bovine skeletal
muscle satellite cells. In vitro Cell Dev Biol Anim. 49:785–797.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Santella L, Kyozuka K, De Riso L and
Carafoli E: Calcium, protease action, and the regulation of the
cell cycle. Cell Calcium. 23:123–130. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang KK: Calpain and caspase: Can you tell
the difference? Trends Neurosci. 23:20–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Braun C, Engel M, Seifert M, Theisinger B,
Seitz G, Zang KD and Welter C: Expression of calpain I messenger
RNA in human renal cell carcinoma: Correlation with lymph node
metastasis and histological type. Int J Cancer. 84:6–9. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Delmas C, Aragou N, Poussard S, Cottin P,
Darbon JM and Manenti S: MAP kinase-dependent degradation of
p27Kip1 by calpains in choroidal melanoma cells. Requirement of
p27Kip1 nuclear export. J Biol Chem. 278:12443–12451. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ma D, Fang J, Liu Y, Song JJ, Wang YQ, Xia
J, Cheng B and Wang Z: High level of calpain1 promotes cancer cell
invasion and migration in oral squamous cell carcinoma. Oncol Lett.
13:4017–4026. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Salimi R, Bandaru S, Devarakonda S, Gökalp
S, Ala C, Alvandian A, Yener N and Akyürek LM: Blocking the
cleavage of filamin A by calpain inhibitor decreases tumor cell
growth. Anticancer Res. 38:2079–2085. 2018.PubMed/NCBI
|
|
26
|
O'Connell MP, Fiori JL, Baugher KM, Indig
FE, French AD, Camilli TC, Frank BP, Earley R, Hoek KS, Hasskamp
JH, et al: Wnt5A activates the calpain-mediated cleavage of filamin
A. J Invest Dermatol. 129:1782–1789. 2009. View Article : Google Scholar : PubMed/NCBI
|
